+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of thrombotic risk factors in end-stage renal disease



Role of thrombotic risk factors in end-stage renal disease



Clinical and Applied Thrombosis/Hemostasis 16(2): 132-140



Genetic polymorphisms that are found among factors of the coagulation cascade are factor V leiden mutation (FVL), prothrombin (PT), and methylenetetrahydrofolate reductase (MTHFR), reported for thrombotic complications. We have investigated the associations of these gene polymorphisms in patients with end-stage renal disease (ESRD). We genotyped 258 patients for FV G1691A, PT G20210A, and MTHFR (C677T, A1298C) gene by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis and were compared with 569 healthy controls. Serum folate, total homocysteine (tHcys), and vitamin B(12) were measured in both patients with ESRD and controls. No homozygous individuals for the mutant AA genotype of FVL G1691A were observed in this study. The frequency of the heterozygous genotypes was (11.2%), which was nearly 3 times higher than that observed in controls (3.2%), with a odds ratio of 3.87 (P = .0001, 95% CI = 2.11-7.11). PT G20210A mutation was missing in both patients and the controls. At MTHFR locus, TT genotype of C677T was present in 9.6% among ESRD, while CC genotype of A1298C was present in 11.7% of the ESRD. In control group, it was significantly low that is, 4.2% and 3.2%, respectively (P = .0034; OR = 2.44, 95% CI = 1.36-4.36 and P < .0001; OR = 4.03; 95% CI = 2.2-7.37). The combined analysis of the 2 genotypes showed further increased risk in ESRD ~15 folds. Further, the carrier of TT and CC genotypes of C677T and A1298C had significantly higher total homocysteine (tHcys) level than those with CC and AA genotypes (P < .001). The carrier of FVL, TT genotype of C677T, and CC genotype of A1298C polymorphisms may act as risk factors for ESRD.

(PDF emailed within 0-6 h: $19.90)

Accession: 055614841

Download citation: RISBibTeXText

PMID: 19520684

DOI: 10.1177/1076029609335911


Related references

Thrombotic and vascular pathogenesis in end stage renal disease Role of fibrinolytic deficit. Modern Pathology 16(1): 54A, January, 2003

Enhanced Inflammatory response in cancer patients with end stage renal disease. Implications in thrombotic risk stratification. Journal of Clinical Oncology 23(16_suppl): 8238-8238, 2016

Is the association between family history of renal disease and end-stage renal disease explained by concurrent aggregation of risk factors?. Journal of the American Society of Nephrology 7(9): 1322, 1996

Hemolytic-uremic syndrome and thrombotic-thrombocytopenic purpura in adults Clinical findings and prognostic factors for death and end-stage renal disease. Nephrology Dialysis Transplantation 10(6): 995, 1995

Haemolytic-uraemic syndrome and thrombotic-thrombocytopenic purpura in adults: clinical findings and prognostic factors for death and end-stage renal disease. Nephrology, Dialysis, Transplantation 13(1): 76-81, 1998

Role of thrombotic vascular risk factors in inflammatory bowel disease. Digestive Diseases 18(3): 161-167, 2001

Why are maternally separated females inflexible? Brain activity pattern of COx and c-Fos. Neurobiology of Learning and Memory: -, 2018

Prevalence of chronic kidney disease and associated risk factors, and risk of end-stage renal disease: data from the PREVADIAB study. Nephron. Clinical Practice 119(1): C35-C40, 2012

The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. Journal of Thrombosis and Haemostasis 3(12): 2671-2676, 2005

Risk factors associated with end-stage renal disease (ESRD) in patients with atherosclerotic renal artery stenosis: a nationwide population-based analysis. Medicine 94(21): E912-E912, 2015

Risk factors for end-stage renal disease among minorities. Transplantation Proceedings 25(4): 2415-2420, 1993

Novel cardiovascular risk factors in end-stage renal disease. Journal of the American Society of Nephrology 15 Suppl 1: S77-S80, 2003

The risk factors for end-stage renal disease in autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation 15(9): A60, September, 2000

Non-traditional cardiovascular disease risk factors in end-stage renal disease: oxidate stress and hyperhomocysteinemia. Current Opinion in Nephrology and Hypertension 9(5): 477-487, 2000

The challenge of cardiovascular risk factors in end-stage renal disease. Journal of Nephrology 16(4): 476-486, 2003